Bromouridine (BrU)-labeled RNA Immunoprecipitation and Bru-Seq

XW Xue Wu
CN Cristina M. Niculite
MP Mihai Bogdan Preda
AR Annalisa Rossi
TT Toma Tebaldi
EB Elena Butoi
MW Mattie K. White
OT Oana M. Tudoran
DP Daniela N. Petrusca
AJ Amber S. Jannasch
WB William P. Bone
XZ Xingyue Zong
FF Fang Fang
AB Alexandrina Burlacu
MP Michelle T. Paulsen
BH Brad A. Hancock
GS George E. Sandusky
SM Sumegha Mitra
MF Melissa L. Fishel
AB Aaron Buechlein
CI Cristina Ivan
SO Spyros Oikonomopoulos
MG Myriam Gorospe
AM Amber Mosley
MR Milan Radovich
UD Utpal P. Davé
JR Jiannis Ragoussis
KN Kenneth P. Nephew
BM Bernard Mari
AM Alan McIntyre
HK Heiko Konig
ML Mats Ljungman
DC Diana L. Cousminer
PM Paolo Macchi
MI Mircea Ivan
request Request a Protocol
ask Ask a question
Favorite

BrU labeling of newly synthesized RNA and BrU-RNA isolation were performed following the method established by Ljungman’s group22. Briefly, MCF-7 cells transfected with either control siRNA or lincNORS siRNA were cultured in hypoxic conditions. BrU (Sigma-Aldrich 850187) at a final concentration of 2 mM was added to the plate when cells reached ~80% confluency. After labeling for 30 min, cells were harvested for total RNA extraction. BrU-labeled RNA was immunoprecipitated from the total RNA using anti-BrdU antibody (BD Pharmingen, 555627) conjugated with Dynabeads® Goat anti-mouse IgG beads (Invitrogen #11033). After 1-h incubation, beads were washed three times with 0.1% BSA in DEPC-PBS to remove unbound RNA then heated at 95 °C for 10 min to recover the BrU-RNA from the beads. The BrU-RNA and the input RNA were analyzed using qPCR. The same BrU-RNA isolation procedure was performed with MCF-7 cells cultured in 21% or 1% O2 and the BrU-labeled RNA was sequenced at the University of Michigan Sequencing Core using Illumina HiSeq2000 sequencer.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A